Agf Investments Inc. Biogen Inc. Transaction History

Agf Investments Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 10, 2022	SELL	$193.77 - $244.14 $289,879 - $365,233	-1,496 Closed	0 $0
Q4 2021 Feb 01, 2022	BUY	$223.92 - $287.77 $334,984 - $430,503	1,496 New	1,496 $359,000
Q2 2021 Aug 10, 2021	SELL	$259.0 - $414.71 $285,159 - $456,595	-1,101 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$242.95 - $284.63 $781,327 - $915,370	-3,216 Reduced 74.5%	1,101 $308,000
Q4 2020 Feb 08, 2021	BUY	$236.26 - $355.63 $299,105 - $450,227	1,266 Added 41.49%	4,317 $1.06 Million
Q3 2020 Nov 12, 2020	BUY	$264.77 - $305.71 $27,006 - $31,182	102 Added 3.46%	3,051 $866,000
Q2 2020 Aug 11, 2020	SELL	$258.66 - $342.55 $76,304 - $101,052	-295 Reduced 9.09%	2,949 $789,000
Q1 2020 May 08, 2020	BUY	$268.85 - $341.04 $872,149 - $1.11 Million	3,244 New	3,244 $1.03 Million

1,018

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Agf Investments Inc., based on Form 13F filings with the SEC.

Stay updated on Agf Investments Inc. with notifications on news.